GB201405275D0 - Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof - Google Patents

Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof

Info

Publication number
GB201405275D0
GB201405275D0 GB201405275A GB201405275A GB201405275D0 GB 201405275 D0 GB201405275 D0 GB 201405275D0 GB 201405275 A GB201405275 A GB 201405275A GB 201405275 A GB201405275 A GB 201405275A GB 201405275 D0 GB201405275 D0 GB 201405275D0
Authority
GB
United Kingdom
Prior art keywords
lgg2
domains
therapeutic use
modified antibodies
antibodies containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201405275A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southampton
Original Assignee
University of Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southampton filed Critical University of Southampton
Priority to GB201405275A priority Critical patent/GB201405275D0/en
Publication of GB201405275D0 publication Critical patent/GB201405275D0/en
Priority to AU2015237864A priority patent/AU2015237864B2/en
Priority to CN202111024797.5A priority patent/CN113912723A/en
Priority to CN201580023010.XA priority patent/CN107172880B/en
Priority to PCT/IB2015/052166 priority patent/WO2015145360A1/en
Priority to EP15716147.2A priority patent/EP3122779B1/en
Priority to CA2943167A priority patent/CA2943167A1/en
Priority to EP19175308.6A priority patent/EP3590967A1/en
Priority to US15/128,781 priority patent/US11059898B2/en
Priority to JP2017501529A priority patent/JP6682498B2/en
Priority to JP2019204004A priority patent/JP2020037577A/en
Priority to US17/327,837 priority patent/US20210347907A1/en
Ceased legal-status Critical Current

Links

GB201405275A 2014-03-24 2014-03-25 Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof Ceased GB201405275D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB201405275A GB201405275D0 (en) 2014-03-25 2014-03-25 Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof
JP2017501529A JP6682498B2 (en) 2014-03-24 2015-03-24 Modified antibodies containing modified IgG2 domains that induce agonistic or antagonistic properties and uses thereof
PCT/IB2015/052166 WO2015145360A1 (en) 2014-03-24 2015-03-24 Modified antibodies containing modified igg2 domains which elicit agonist or antagonistic properties and use thereof
CN202111024797.5A CN113912723A (en) 2014-03-24 2015-03-24 Modified antibodies comprising a modified IgG2 domain that elicit agonistic or antagonistic properties and uses thereof
CN201580023010.XA CN107172880B (en) 2014-03-24 2015-03-24 Modified antibodies comprising a modified IgG2 domain that elicit agonistic or antagonistic properties and uses thereof
AU2015237864A AU2015237864B2 (en) 2014-03-24 2015-03-24 Modified antibodies containing modified IgG2 domains which elicit agonist or antagonistic properties and use thereof
EP15716147.2A EP3122779B1 (en) 2014-03-24 2015-03-24 Modified antibodies containing modified igg2 domains which elicit agonist or antagonistic properties and use thereof
CA2943167A CA2943167A1 (en) 2014-03-24 2015-03-24 Modified antibodies containing modified igg2 domains which elicit agonist or antagonistic properties and use thereof
EP19175308.6A EP3590967A1 (en) 2014-03-24 2015-03-24 Modified antibodies containing modified igg2 domains which elicit agonist properties and use thereof
US15/128,781 US11059898B2 (en) 2014-03-24 2015-03-24 Modified antibodies containing modified IGG2 domains which elicit agonist or antagonistic properties and use thereof
JP2019204004A JP2020037577A (en) 2014-03-24 2019-11-11 MODIFIED ANTIBODIES CONTAINING MODIFIED IgG2 DOMAINS WHICH ELICIT AGONISTIC OR ANTAGONISTIC PROPERTIES AND USE THEREOF
US17/327,837 US20210347907A1 (en) 2014-03-24 2021-05-24 Modified antibodies containing modified igg2 domains which elicit agonist or antagonistic properties and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201405275A GB201405275D0 (en) 2014-03-25 2014-03-25 Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof

Publications (1)

Publication Number Publication Date
GB201405275D0 true GB201405275D0 (en) 2014-05-07

Family

ID=50686836

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201405275A Ceased GB201405275D0 (en) 2014-03-24 2014-03-25 Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof

Country Status (1)

Country Link
GB (1) GB201405275D0 (en)

Similar Documents

Publication Publication Date Title
IL304178A (en) Anti-gitr antibodies and methods of use thereof
IL279606A (en) Anti-trem2 antibodies and methods of use thereof
HK1245807A1 (en) Anti-mertk agonistic antibodies and uses thereof
HK1249445A1 (en) Anti-sortilin antibodies and methods of use thereof
IL259495A (en) Antibodies and methods of use thereof
HK1252698A1 (en) Anti-siglec-9 antibodies and methods of use thereof
HK1252696A1 (en) Anti-siglec-7 antibodies and methods of use thereof
SG10201912150TA (en) Anti-trem2 antibodies and methods of use thereof
ZA202001985B (en) Anti-htra1 antibodies and methods of use thereof
IL250428B (en) Antagonistic anti-ox40l antibodies and methods of their use
GB201405275D0 (en) Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof
GB201405264D0 (en) Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)